Prosecution Insights
Last updated: October 02, 2026
Application No. 18/847,898

A METHOD OF PRODUCING EXPLOSIVE HMX BY FLOW SYNETHESIS

Non-Final OA §103
Filed
Sep 17, 2024
Priority
Mar 21, 2022 — GB 2203917.6 +1 more
Examiner
SAEED, KAMAL A
Art Unit
Tech Center
Assignee
BAE Systems plc
OA Round
2 (Non-Final)
84%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
1018 granted / 1214 resolved
+23.9% vs TC avg
Moderate +10% lift
Without
With
+9.8%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 0m
Avg Prosecution
32 currently pending
Career history
1227
Total Applications
across all art units

Statute-Specific Performance

§101
2.5%
-37.5% vs TC avg
§103
9.0%
-31.0% vs TC avg
§102
6.9%
-33.1% vs TC avg
§112
16.6%
-23.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1214 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Please Note: The Office Action mailed on July 16, 2026, is vacated. The following is a new Office Action. Claims 1-10 are currently pending in this Application. Priority CONTINUING DATA This application is a 371 of PCT/GB2023/050566 03/10/2023 FOREIGN APPLICATIONS UNITED KINGDOM 2203917.6 03/21/2022 Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-4 and 9-10 are rejected under 35 U.S.C. 103 as being unpatentable over US Patent No.3,939,148 A, in view of KYPRINAOU DIMITRIS et al., "Flow chemistry and the synthesis of energetic materials," JRC Technical Report, Luxembourg Publications Office of the European Union (2022). Claim 1 of the present invention is drawn to a method for the manufacture of the relatively in- sensitive nitroamine explosive called "HMX", also known as 1,3,5,7-tetranitro-1,3,5,7-tetraazacyclooctane. The method comprises, an input flow mixture comprising "TAT" (1,3,5,7-tetraacetyl-1,3,5,7-tetraazacyclooctane) with nitric acid of >95% in combination with P2O5, at temperatures of 60 to 80°C in a flow reactor to control the rate of production of explosive material. Claim 2 further defines the method wherein the reacted admixture is cooled to precipitate the HMX. Claim 3 further defines the concentration of the nitic acid concentration. Claim 4 further defines the heating of the reaction chamber in the method and the temperature range of the reaction chamber. Claims 9 and 10 further define the ratio of the reactants in the method and reaction steps prior to the input flow admixture. Determining the scope and contents of the prior art. (See MPEP § 2141.01) In regards, to claims 1-4 and 9-10, US Patent No.3,939,148 A teaches a method directed to the preparation of HMX starting from TAT by use of HNO3/P2O5 at elevated temperatures of up to 90°C, see claims 1-3, 8, 11 and 18, while the procedures of examples 1-14 and table 1 apply 50 to 70°C. US Patent No.3,939,148 A does not teach flow chemistry in the process. KYPRINAOU DIMITRIS et al. teaches the application of flow chemistry specifically for the synthesis of energetic materials, i.e., explosives, propellants, and pyrotechnics. Chapters 2.1, 2.4 and 3.1 explain the principle and the advantages, in particular why flow chemistry is considered inherently safer than batch synthesis. Finding of prima facie obviousness --- rationale and motivation (See MPEP § 2142-2143) The Supreme Court in KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 415-421, 82 USPQ2d 1385, 1395-97 (2007) identified a number of rationales to support a conclusion of obviousness which are consistent with the proper "functional approach" to the determination of obviousness as laid down in Graham. See MPEP 2143. Examples of rationales that may support a conclusion of obviousness include: (A) Combining prior art elements according to known methods to yield predictable results; (B) Simple substitution of one known element for another to obtain predictable results; (C) Use of known technique to improve similar devices (methods, or products) in the same way; (D) Applying a known technique to a known device (method, or product) ready for improvement to yield predictable results; (E) "Obvious to try" — choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success; (F) Known work in one field of endeavor may prompt variations of it for use in either the same field or a different one based on design incentives or other market forces if the variations are predictable to one of ordinary skill in the art. (G) Some teaching, suggestions, or motivation in the prior art that would have led one of ordinary skill to modify the prior art reference or to combine prior art reference teachings to arrive at the claimed invention. Note that the list of rationales provided is not intended to be an all-inclusive list. Other rationales to support a conclusion of obviousness may be relied upon by Office personnel. Here one or more rationales (C) and (G) apply. It would have been prima facie obvious for a person of ordinary skill in the art before the effective filing date of the claimed invention to use the teachings of US Patent No.3,939,148 A to explore using a flow reactor to control the rate of production of explosive material as the instantly claimed invention. Since KYPRINAOU DIMITRIS et al. teaches the application of flow chemistry specifically for the synthesis of energetic materials, i.e., explosives, propellants, and pyrotechnics. One skilled in art would have been motivated to consider using a flow reactor to control the rate of production of explosive material as the instantly claimed invention. A reference is good not only for what it teaches by direct anticipation but also for what one of ordinary skill in the art might reasonably infer from the teachings. (In re Opprecht 12 USPQ 2d 1235, 1236 (Fed Cir. 1989); In re Bode 193 USPQ 12 (CCPA) 1976). In light of the foregoing discussion, the Examiner concludes that the subject matter defined by the instant claims would have been obvious within the meaning of 35 USC 103(a). From the teachings of the references, it is apparent that one of ordinary skill in the art would have had a reasonable expectation of success in producing the claimed invention. Therefore, the invention as a whole was prima facie obvious to one of ordinary skill in the art at the time the invention was made, as evidenced by the references, especially in the absence of evidence to the contrary. Accordingly, claims 1-4 and 9-10 are rendered obvious in view of the references above. Applicant may wish to consider providing evidence of unexpected results to overcome the obviousness rejection. Therefore, the present claims are prima facie obvious and properly rejected. Claim Objections Claims 5-8 are objected to depending on a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The quenching step or quenching agent limitation included in claims 5-8 is not covered or suggested by the prior art. Telephone Inquiry Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAMAL A SAEED whose telephone number is (571) 272-0705. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicants are encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Adam C Milligan can be reached at (571)270-7674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000 /Kamal A Saeed/ Primary Examiner, Art Unit 1626
Read full office action

Prosecution Timeline

Sep 17, 2024
Application Filed
Jul 16, 2026
Non-Final Rejection mailed — §103
Sep 16, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740969
SOLID STATE FORMS OF TIDEGLUSIB AND PROCESS FOR PREPARATION THEREOF
3y 1m to grant Granted Sep 22, 2026
Patent 12735400
BCL-2 Inhibitors
2y 2m to grant Granted Sep 15, 2026
Patent 12728132
INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF
2y 5m to grant Granted Sep 08, 2026
Patent 12723040
BACTERIAL EFFLUX PUMP INHIBITORS
3y 9m to grant Granted Sep 01, 2026
Patent 12721853
APPLICATIONS OF CX-5461 IN TREATING IMMUNE REJECTION IN RENAL TRANSPLANTATION
2y 2m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
84%
Grant Probability
94%
With Interview (+9.8%)
2y 0m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1214 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month